434 related articles for article (PubMed ID: 25446361)
1. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
2. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
[TBL] [Abstract][Full Text] [Related]
3. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780
[TBL] [Abstract][Full Text] [Related]
4. Serum Response Factor Promotes Dopaminergic Neuron Survival via Activation of Beclin 1-Dependent Autophagy.
Cheng XY; Li SY; Mao CJ; Wang MX; Chen J; Wang F; Wang GH; Deng WB; Li XK; Liu CF
Neuroscience; 2018 Feb; 371():288-295. PubMed ID: 29196028
[TBL] [Abstract][Full Text] [Related]
5. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
[TBL] [Abstract][Full Text] [Related]
6. TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells.
Wang MX; Cheng XY; Jin M; Cao YL; Yang YP; Wang JD; Li Q; Wang F; Hu LF; Liu CF
Exp Neurol; 2015 Sep; 271():112-21. PubMed ID: 26001614
[TBL] [Abstract][Full Text] [Related]
7. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
Azimullah S; Jayaraj RL; Meeran MFN; Jalal FY; Adem A; Ojha S; Beiram R
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677744
[TBL] [Abstract][Full Text] [Related]
8. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
9. Is trehalose an autophagic inducer? Unraveling the roles of non-reducing disaccharides on autophagic flux and alpha-synuclein aggregation.
Yoon YS; Cho ED; Jung Ahn W; Won Lee K; Lee SJ; Lee HJ
Cell Death Dis; 2017 Oct; 8(10):e3091. PubMed ID: 28981090
[TBL] [Abstract][Full Text] [Related]
10. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.
De Miranda BR; Fazzari M; Rocha EM; Castro S; Greenamyre JT
Toxicol Sci; 2019 Jul; 170(1):133-143. PubMed ID: 30907971
[TBL] [Abstract][Full Text] [Related]
12. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
[TBL] [Abstract][Full Text] [Related]
13. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
15. Molecular Association of Glia Maturation Factor with the Autophagic Machinery in Rat Dopaminergic Neurons: a Role for Endoplasmic Reticulum Stress and MAPK Activation.
Selvakumar GP; Iyer SS; Kempuraj D; Ahmed ME; Thangavel R; Dubova I; Raikwar SP; Zaheer S; Zaheer A
Mol Neurobiol; 2019 Jun; 56(6):3865-3881. PubMed ID: 30218400
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA
Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688
[TBL] [Abstract][Full Text] [Related]
17. Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease.
Moon SH; Kwon Y; Huh YE; Choi HJ
Arch Pharm Res; 2022 Jun; 45(6):417-432. PubMed ID: 35618982
[TBL] [Abstract][Full Text] [Related]
18. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
19. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
Kang SY; Lee SB; Kim HJ; Kim HT; Yang HO; Jang W
Neurosci Lett; 2017 Mar; 642():20-26. PubMed ID: 28137648
[TBL] [Abstract][Full Text] [Related]
20. Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease.
Dong H; Qin Y; Huang Y; Ji D; Wu F
Neurochem Int; 2019 Jun; 126():178-186. PubMed ID: 30904670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
